News

Kashiv BioSciences, LLC has announced a licensing and supply agreement with Brazilian pharmaceutical giant CRISTÁLIA for the commercialization of ADL-018, a proposed biosimilar to…
Read More...

Scipher Medicine, known for its AI-driven precision immunology platform, has announced a strategic collaboration with Maxymune Therapeutics, a biotech company focused on novel…
Read More...

Kytopen Corp., a leader in continuous flow cellular engineering, has announced a collaboration with BlueWhale Bio, a company focused on advancing cell-based therapies by revolutionizing…
Read More...

In a sweeping move to restore public trust in pharmaceutical advertising, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) today…
Read More...

Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INLEXZO (gemcitabine intravesical system), a novel treatment for adults with Bacillus…
Read More...

Teva Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational therapy emrusolmin (TEV-56286) for the…
Read More...

Novartis announced it has agreed to acquire Tourmaline Bio, a clinical-stage biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 monoclonal antibody designed to…
Read More...

Medison and Ipsen announced that Health Canada has approved Bylvay (odevixibat) for the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille Syndrome…
Read More...

Servier, an international pharmaceutical group, has announced the acquisition of KER-0193, a promising potential treatment for Fragile X syndrome (FXS) from UK-based biotech Kaerus…
Read More...

Eli Lilly and Company announced positive topline results from the Phase 3 BRUIN CLL-313 clinical trial evaluating Jaypirca (pirtobrutinib) in treatment-naïve patients with chronic…
Read More...

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasib, in combination with KEYTRUDA…
Read More...

Argo Biopharmaceutical Co., Ltd., a clinical-stage biotech focused on next-generation siRNA therapies, has announced a new strategic collaboration with Novartis to develop multiple…
Read More...

AbbVie announced that Health Canada has approved ELAHERE® (mirvetuximab soravtansine for injection) under the Priority Review process. ELAHERE is an antibody-drug conjugate (ADC)…
Read More...

Avadel Pharmaceuticals plc, a biopharmaceutical company dedicated to advancing treatments for sleep disorders, has entered into an exclusive global license agreement with XWPharma Ltd.…
Read More...

The U.S. Food and Drug Administration introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat…
Read More...

Gilead Sciences, Inc. announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) to deliver lenacapavir—Gilead's…
Read More...

Illumina Inc. has officially launched Illumina Protein Prep, a new assay designed to enhance next-generation sequencing (NGS)-based proteomics discovery at scale. Previously available…
Read More...

Amgen has announced plans to invest more than $600 million in a cutting-edge center for science and innovation at its global headquarters in Thousand Oaks, California. The new facility…
Read More...

Quotient Sciences, a global leader in drug development and manufacturing acceleration, has joined forces with UK technology innovation centre CPI to form a joint venture (JV) focused on…
Read More...

Thermo Fisher Scientific Inc. announced the completion of its acquisition of Sanofi’s sterile fill-finish and packaging facility in Ridgefield, New Jersey, expanding its strategic…
Read More...